Table 1.
Abbreviation.
| Acronym | Corresponding English |
|---|---|
| AD | Alzheimer's disease |
| AChE | Acetylcholinesterase |
| AGEs | Advanced glycation endproducts |
| BACE1 | β-Secretase 1 |
| BMECs | Brain microvascular endothelial cells |
| CAT | Catalpol |
| ChAT | Acetyltransferase |
| CK | Creatine kinase |
| COX-2 | Cyclooxygenase-2 |
| ERK | Extracellular signal-regulated kinase |
| EPO | Erythropoietin |
| GPx | Glutathione peroxidase |
| GSH | Glutathione |
| GSH-PX | Glutathione peroxidase |
| GS | Glutamine synthetase |
| H2O2 | Hydrogen peroxide |
| IL | Interleukin |
| IDE | Insulin-degrad |
| iNOS | Inducible nitric oxide synthase |
| IRX3 | Iroquois homeobox protein 3 |
| LDH | Lactate dehydrogenase |
| LPS | Lipopolysaccharide |
| MDA | Malondialdehyde |
| MMP | Mitochondrial membrane potential |
| mAChR1 | Muscarinic acetylcholine receptor M1 |
| MAP-2 | Microtubule-associated protein 2 |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| MS | Multiple sclerosis |
| NO | Nitric oxide |
| NF-κB | Nuclear factor-κB |
| NEP | Neprilysin |
| OGD | Oxygen-glucose deprivation |
| OLGs | Oligodendrocytes |
| p-CREB | Phosphorylated cAMP-responsive element-binding protein |
| PD | Parkinson's disease |
| PKC | Protein kinase C |
| PMA | Phorbol-12-myristate-13-acetate |
| PARP-1 | Poly-ADP-ribose polymerase-1 |
| ROS | Reactive oxygen species |
| SOD | Superoxide dismutase |
| TNF-α | Tumor necrosis factor α |
| TLR4 | Toll-like receptor 4 |
| TrkB | Tyrosine kinase receptor |
| VEGF | Vascular endothelial growth factor |
| WMLs | White matter lesions |